Marketing Logic has developed a comprehensive system for the distribution and sale of drugs for Novartis

2022: Drug Distribution and Sales System Development

Marketing Logic On September 8, 2022, the company announced the development of pharmaceutical a Novartis comprehensive distributions drug system and implementation for the company. The applied geo marketing technology and analysis big data increased the sales and availability of drugs to patients.

The platform is based on [[|Atlas GIS]]. The implemented system ensures uninterrupted and targeted provision of patients with drugs and responds flexibly to changing needs. Analysis of geodata, as well as information on infrastructure, socio-demographic characteristics of districts and microdistricts, data on the density and location of treatment and preventive institutions, pharmacies and pharmacy chains together with information from medical representatives of the company make it possible to predict the demand for each pharmacy unit, to identify the true need for a drug. The potential of hospitals and clinics and patient profiles are also taken into account. If necessary, the interface displays various indicators in the most visible format of "heat maps."

The solution analyzes demand and keeps a targeted account of the needs of patients to quickly deliver drugs in the necessary quantities to pharmacies and pharmacy chains, reducing the waiting time for the drug by patients. The implemented solution also reduces the warehouse stocks of drugs in pharmacy chains and reduces the financial, time costs of all participants in the supply chain in the pharmaceutical market. Thus, the platform also reduces the environmental burden by reducing the potential volume of unused reserves.

For the convenience and navigation of patients, the platform includes a mobile application with a geotreker. The application shows the presence of a drug in the nearest pharmacy, builds the optimal route and allows you to order the drug at home, if necessary and the storage conditions allow.

Novartis is a very responsible partner. All two years of work on the project, we took into account the rigidity of the requirements for the predictive accuracy of our models and analytics, as well as the social importance of the project. We see the task of providing Russian patients with affordable medicines as one of the most important, and we are ready to continue to work in this direction so that as many people as possible can quickly get the medicine they need wherever they are, "said Dmitry Galkin, managing partner of Marketing Logic.